68 Ga-DOTATOC PET/CT Imaging of a Muscular Solitary Fibrous Tumor.


Journal

Clinical nuclear medicine
ISSN: 1536-0229
Titre abrégé: Clin Nucl Med
Pays: United States
ID NLM: 7611109

Informations de publication

Date de publication:
01 May 2023
Historique:
medline: 5 4 2023
pubmed: 1 3 2023
entrez: 28 2 2023
Statut: ppublish

Résumé

A 73-year-old woman was referred for 68 Ga-DOTATOC PET/CT staging of a grade 2 pancreatic neuroendocrine tumor, which showed the primary pancreatic tumor, liver metastases, one left pleural metastasis, and high uptake in a mass of the right triceps brachii muscle. Two years before, she underwent 18 F-FDG PET/CT and 111 In-pentetreotide scan, respectively, with low and high uptake of each radiotracer in the triceps mass. Histopathological analysis revealed a solitary fibrous tumor. Immunohistochemistry showed no staining for SSTR-2 and SSTR-5, suggesting tumor overexpression of another somatostatin receptor. This case highlighted a potential pitfall on 68 Ga-DOTATOC PET/CT.

Identifiants

pubmed: 36854307
doi: 10.1097/RLU.0000000000004615
pii: 00003072-202305000-00033
doi:

Substances chimiques

Edotreotide U194AS08HZ
Octreotide RWM8CCW8GP
Receptors, Somatostatin 0
Gallium-68 98B30EPP5S
Organometallic Compounds 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e228-e229

Informations de copyright

Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of interest and sources of funding: none declared.

Références

Lococo F, Rufini V, Filice A, et al. 68 Ga-DOTATOC PET/CT in pleural solitary fibrous tumors. Clin Nucl Med . 2021;46:e336–e338.
Parghane RV, Agrawal K, Mittal BR, et al. 68 Ga DOTATATE PET/CT imaging of a solitary fibrous tumor of the nasopharynx. Clin Nucl Med . 2014;39:e382–e383.
Thuillier P, Risson J-R, Eusen Y, et al. Retroperitoneal pelvic solitary fibrous tumor with high tracer uptake in 68 Ga-DOTATOC PET/CT: a rare differential diagnosis of paraganglioma. Clin Nucl Med . 2019;44:e370–e371.
Lavacchi D, Antonuzzo L, Briganti V, et al. Metastatic intracranial solitary fibrous tumors/hemangiopericytomas: description of two cases with radically different behaviors and review of the literature. Anticancer Drugs . 2020;31:646–651.
Bailly C, Bichali Alroumani M, Douane F, et al. Metastatic solitary fibrous tumor with Doege-Potter syndrome: hypoglycemia treated by 90 Y radioembolization. Clin Nucl Med . 2018;43:e93–e95.
Fletcher CDM, Bridge JA, Lee JC. Extrapleural solitary fibrous tumor. In: Fletcher CDM, Bridge JA, Hogendoorn PCW, eds. World Health Organization of Tumors of Soft Tissue and Bone . Lyon, France: IARC Press; 2013:80–82.
Demicco EG, Park MS, Araujo DM, et al. Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model. Mod Pathol . 2012;25:1298–1306.
Parghane RV, Bhandare M, Chaudhari V, et al. Surgical feasibility, determinants, and overall efficacy of neoadjuvant 177 Lu-DOTATATE PRRT for locally advanced unresectable gastroenteropancreatic neuroendocrine tumors. J Nucl Med . 2021;62:1558–1563.
Crespo-Jara A, González Manzano R, Lopera Sierra M, et al. A patient with metastatic sarcoma was successfully treated with radiolabeled somatostatin analogs. Clin Nucl Med . 2016;41:705–707.
Lensing RJ, Broos WAM, van der Zant FM, et al. Focal PSMA-positive pleural lesion in a patient with stage II prostate carcinoma. Clin Nucl Med . 2022;47:e170–e171.
Zhang A, Zhang H, Zhou X, et al. Solitary fibrous tumors of the pleura shown on 18 F-FDG and 68 Ga-DOTA-FAPI-04 PET/CT. Clin Nucl Med . 2021;46:e534–e537.

Auteurs

Capucine Richard (C)

From the Department of Nuclear Medicine and Endocrine Oncology, Institut Curie, Saint-Cloud.

Jérôme Cros (J)

Beaujon Hospital, AP-HP, Department of Pathology, Clichy.

Romain-David Seban (RD)

From the Department of Nuclear Medicine and Endocrine Oncology, Institut Curie, Saint-Cloud.

Laurence Champion (L)

From the Department of Nuclear Medicine and Endocrine Oncology, Institut Curie, Saint-Cloud.

Ségolène Hescot (S)

Institut Curie, Department of Medical Oncology, Saint-Cloud, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH